| 000 | 01394 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250511193904.0 | ||
| 264 | 0 | _c19920716 | |
| 008 | 199207s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRowinsky, E K | |
| 245 | 0 | 0 |
_aHexamethylene bisacetamide in myelodysplastic syndrome: effect of five-day exposure to maximal therapeutic concentrations. _h[electronic resource] |
| 260 |
_bLeukemia _cJun 1992 |
||
| 300 |
_a526-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcetamides _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aDepression, Chemical |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematinics _xadministration & dosage |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xblood |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 700 | 1 | _aConley, B A | |
| 700 | 1 | _aJones, R J | |
| 700 | 1 | _aSpivak, J L | |
| 700 | 1 | _aAuerbach, M | |
| 700 | 1 | _aDonehower, R C | |
| 773 | 0 |
_tLeukemia _gvol. 6 _gno. 6 _gp. 526-34 |
|
| 999 |
_c1609272 _d1609272 |
||